AU2022348500A1 - Multi-tissue organoid products and methods - Google Patents

Multi-tissue organoid products and methods Download PDF

Info

Publication number
AU2022348500A1
AU2022348500A1 AU2022348500A AU2022348500A AU2022348500A1 AU 2022348500 A1 AU2022348500 A1 AU 2022348500A1 AU 2022348500 A AU2022348500 A AU 2022348500A AU 2022348500 A AU2022348500 A AU 2022348500A AU 2022348500 A1 AU2022348500 A1 AU 2022348500A1
Authority
AU
Australia
Prior art keywords
cell
cartilage
cells
mto
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022348500A
Other languages
English (en)
Inventor
Yi Wen Chai
Manci LI
Beth LINDBORG
Timothy D. O'brien
Amanda VEGOE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota System
Original Assignee
University of Minnesota Twin Cities
University of Minnesota System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota Twin Cities, University of Minnesota System filed Critical University of Minnesota Twin Cities
Publication of AU2022348500A1 publication Critical patent/AU2022348500A1/en
Assigned to REGENTS OF THE UNIVERSITY OF MINNESOTA reassignment REGENTS OF THE UNIVERSITY OF MINNESOTA Amend patent request/document other than specification (104) Assignors: Amanda VEGOE, Beth LINDBORG, Manci LI, REGENTS OF THE UNIVERSITY OF MINNESOTA, TIMOTHY D. O'BRIEN, Yi Wen CHAI
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2022348500A 2021-09-16 2022-09-16 Multi-tissue organoid products and methods Pending AU2022348500A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163244991P 2021-09-16 2021-09-16
US63/244,991 2021-09-16
PCT/US2022/043839 WO2023044032A1 (en) 2021-09-16 2022-09-16 Multi-tissue organoid products and methods

Publications (1)

Publication Number Publication Date
AU2022348500A1 true AU2022348500A1 (en) 2024-03-21

Family

ID=85602037

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022348500A Pending AU2022348500A1 (en) 2021-09-16 2022-09-16 Multi-tissue organoid products and methods

Country Status (6)

Country Link
US (1) US20240271105A1 (enExample)
EP (1) EP4402248A4 (enExample)
JP (1) JP2024534435A (enExample)
AU (1) AU2022348500A1 (enExample)
CA (1) CA3232587A1 (enExample)
WO (1) WO2023044032A1 (enExample)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200000823A (ko) * 2018-06-25 2020-01-03 주식회사 씨아이에스티이엠 인간 유도 만능 줄기세포로부터 연골세포의 펠렛을 제조하는 방법 및 이의 용도
JP2022514298A (ja) * 2018-12-19 2022-02-10 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ オルガノイドおよびその組織を作製および使用するための方法

Also Published As

Publication number Publication date
EP4402248A1 (en) 2024-07-24
US20240271105A1 (en) 2024-08-15
WO2023044032A1 (en) 2023-03-23
EP4402248A4 (en) 2025-11-26
JP2024534435A (ja) 2024-09-20
CA3232587A1 (en) 2023-03-23

Similar Documents

Publication Publication Date Title
CN100412188C (zh) 生物活性天然生物基质组合物
US20190352603A1 (en) Neural cell extracellular vessicles
Azari et al. Effects of transplanted mesenchymal stem cells isolated from Wharton’s jelly of caprine umbilical cord on cutaneous wound healing; histopathological evaluation
CN101801396B (zh) 治疗神经变性的方法和组合物
Kong et al. hiPSC-derived NSCs effectively promote the functional recovery of acute spinal cord injury in mice
JP7350344B2 (ja) ヒト誘導万能幹細胞から軟骨細胞のペレットを製造する方法およびその用途
US20160361365A1 (en) Treatment of cns disease with encapsulated inducible choroid plexus cells
CN1170434A (zh) 体外诱导多巴胺能的细胞
US12533383B2 (en) Method for producing cell aggregate including glial progenitor cells
KR20060037346A (ko) 휘돌기교세포 전구세포 및 이를 획득하고 배양하는 방법
Zhang et al. Reducing host aldose reductase activity promotes neuronal differentiation of transplanted neural stem cells at spinal cord injury sites and facilitates locomotion recovery
Wu et al. Interaction of NG2+ glial progenitors and microglia/macrophages from the injured spinal cord
CN111320682A (zh) 多肽在制备促进软骨修复和/或治疗骨关节炎药物中的用途
Chen et al. Schwann cells induce proliferation and migration of oligodendrocyte precursor cells through secretion of PDGF-AA and FGF-2
CN110903381B (zh) 一种促进软骨再生的肽kai 11及其应用
US20240271105A1 (en) Multi-tissue organoid products and methods
Deng et al. Extracellular matrix-regulated neural differentiation of human multipotent marrow progenitor cells enhances functional recovery after spinal cord injury
Xie et al. Effect of a subset of adipose‐derived stem cells isolated with liposome magnetic beads to promote cartilage repair
CN111566204B (zh) 培养细胞的制造方法、脊髓损伤疾病的治疗剂的制造方法
Liu et al. Stem cell therapy for hearing loss: Math1 overexpression in VOT-E36 cells
US20230295571A1 (en) Compositions and methods for stem cell chondrogenesis
TW202313090A (zh) 天麻素於預防或治療肌萎縮性脊髓側索硬化症的用途
Aeri et al. Veterinary regenerative medicine: the evolving role of stem cell-based therapies
Yang et al. Transplantation of Schwann cells differentiated from adipose-derived stem cells modifies reactive gliosis after contusion brain injury in rats
Lin et al. MSCs transplantation enhances synaptic plasticity in intracerebral hemorrhagic rats through the mTOR/P70S6K signaling pathway

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: REGENTS OF THE UNIVERSITY OF MINNESOTA

Free format text: FORMER NAME(S): REGENTS OF THE UNIVERSITY OF MINNESOTA; TIMOTHY D. O'BRIEN; BETH LINDBORG; AMANDA VEGOE; YI WEN CHAI; MANCI LI